It was study found that TFE3-positive RCC groups (Xp11.2 translocation RCC and TFE3-positive non-Xp11.2 translocation RCC) showed significantly aggressive clinicopathological characteristics and poor prognosis as compared with the TFE3-negtive RCC group. Here, TFE3 is linked to renal cell carcinoma.